• News
  • SAN DIEGO
  • BioTech

La Jolla Pharma, Senomyx added to Russell indexes

At least two local drug firms were added to the Russell stock indexes when they were reconfigured last week, designed to provide a barometer for smaller stocks trading on the national exchanges.

La Jolla Pharmaceutical Co. (Nasdaq: LJPC), which develops therapies for life-threatening diseases, and Senomyx Inc. (Nasdaq: SNMX), which develops novel flavors for foods and beverages, were both added to the Russell Microcap Index comprising the smallest 1,000 securities in the Russell 2000 Index.

George Tidmarsh, La Jolla Pharmaceutical’s CEO, says he expects that inclusion in the index “will increase the liquidity of our stock and expose us to a wide range of institutions, investors and index funds that reference them.”

Inclusion on the microcap list also means the firms are now on the Russell 2000 and Russell 3000 lists.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

La Jolla Pharmaceutical Co.

Company Website

6455 Nancy Ridge Dr.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
LJPC
23.87
  -0.82  
- 3.32%
149,217,000
44.99
7.97

Insider Trade Data

Date Insider Shares Type Value
09/28/2015 Chawla, Lakhmir S 485 Purchase $13,461
09/28/2015 Chawla, Lakhmir S 485 Purchase $13,461
09/10/2015 Tang, Kevin C 80,000 Purchase $3,040,000
09/10/2015 Tang, Kevin C 80,000 Purchase $3,040,000
08/21/2015 Tang, Kevin C 170,000 Purchase $4,609,230

La Jolla Pharmaceutical Co. Executive(s):

Deirdre Gillespie

  • Chief Executive Officer, President

George Tidmarsh

  • Chief Executive Officer, President

Similar Companies

NAICS - 541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Subscribe Today!